Daniel Kaufmann
11Patents
1h-index
25Co-inventors
50Inventor score
Filing activity: Feb 7, 2001 → Nov 12, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8580974B2 | Processes | Emerging Cross-Sectional Technologies | 6 | Active |
| US7112673B2 | Dibenzo [b,f]azepine intermediates | Human Necessities | 1 | Expired |
| US7579467B2 | N-phenyl-2-pyrimidine-amine derivatives | Chemistry; Metallurgy | 1 | Active |
| US9061973B2 | Processes for producing NEP inhibitors or prodrugs thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US7816359B2 | N-phenyl-2-pyrimidine-amine derivatives | Chemistry; Metallurgy | 1 | Active |
| US8252310B2 | Manufacture process | Chemistry; Metallurgy | 1 | Active |
| US7825247B2 | N-phenyl-2-pyrimidine-amine derivatives | Chemistry; Metallurgy | 0 | Active |
| US9227934B2 | Processes for producing NEP inhibitors or prodrugs thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US7456283B2 | N-phenyl-2-pyrimidine-amine derivatives | Chemistry; Metallurgy | 0 | Expired |
| US9403766B2 | Intermediates for producing NEP inhibitors or prodrugs thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9573928B2 | N-phenyl-2-pyrimidine-amine derivatives | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.